Which is the preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment? Full Text
Cardiovascular Diabetology,

Mallat SG – Clinical studies suggest that in CV high–risk patients and those with evidence of renal disease, the use of an ARB/CCB combination may be preferred to ARB/HCTZ combinations due to superior renoprotective and CV benefits and reduced metabolic side effects in patients with concomitant metabolic disorders. However, selection of the most appropriate antihypertensive combination should be dependent on careful review of the individual patient and appropriate consideration of drug pharmacology.

  • Hypertension is a major associated risk for organ damage and mortality, which is further heightened in patients with prior cardiovascular (CV) events, comorbid diabetes mellitus, microalbuminuria and renal impairment.
  • Given that most patients with hypertension require at least two antihypertensives to achieve blood pressure (BP) goals, identifying the most appropriate combination regimen based on individual risk factors and comorbidities is important for risk management.
  • Single–pill combinations (SPCs) containing two or more antihypertensive agents with complementary mechanisms of action offer potential advantages over free–drug combinations, including simplification of treatment regimens, convenience and reduced costs.
  • The improved adherence and convenience resulting from SPC use is recognised in updated hypertension guidelines.
  • Despite a wide choice of SPCs for hypertension treatment, clinical evidence from direct head–to–head comparisons to guide selection for individual patients is lacking.
  • However, in patients with evidence of renal disease or at greater risk of developing renal disease, such as those with diabetes mellitus, microalbuminuria and high–normal BP or overt hypertension, guidelines recommend renin–angiotensin system (RAS) blocker–based combination therapy due to superior renoprotective effects compared with other antihypertensive classes.
  • Furthermore, RAS inhibitors attenuate the oedema and renal hyperfiltration associated with calcium channel blocker (CCB) monotherapy, making them a good choice for combination therapy.
  • The occurrence of angiotensin–converting enzyme (ACE) inhibitor–induced cough supports the use of angiotensin II receptor blockers (ARBs) for RAS blockade rather than ACE inhibitors.
  • In this regard, ARB–based SPCs are available in combination with the diuretic, hydrochlorothiazide (HCTZ) or the calcium CCB, amlodipine.
  • Telmisartan, a long–acting ARB with preferential pharmacodynamic profile compared with several other ARBs, and the only ARB with an indication for the prevention of CV disease progression, is available in two SPC formulations, telmisartan/HCTZ and telmisartan/amlodipine.

Please login or register to follow this author.
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Ophthalmology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Ophthalmology Articles

1 Subjective complaints after cataract surgery: Common causes and management strategies Current Opinion in Ophthalmology, December 10, 2014    Clinical Article

2 Subjective complaints after cataract surgery: Common causes and management strategies Current Opinion in Ophthalmology, January 19, 2015    Review Article

3 Incidence of postoperative endophthalmitis from 1990 to 2009 using povidone-iodine but no intracameral antibiotics at a single academic institution Journal of Cataract & Refractive Surgery, January 7, 2015    Evidence Based Medicine    Clinical Article

4 Top-selling eye vitamins found not to match scientific evidence American Academy of Ophthalmology News, December 10, 2014

5 Original and generic latanoprost for the treatment of glaucoma and ocular hypertension: are they really the same? Clinical and Experimental Pharmacology and Physiology, October 29, 2014    Clinical Article

6 Oral treatment with the melatonin agonist agomelatine lowers the intraocular pressure of glaucoma patients Ophthalmic and Physiological Optics, January 23, 2015    Clinical Article

7 Phakic intraocular lens explantation: causes in 240 cases Journal of Refractive Surgery, January 16, 2015    Clinical Article

8 Ex-press glaucoma filtration device: Review of clinical experience and comparison with trabeculectomy Survey of Ophthalmology, January 30, 2015    Clinical Article

9 Mini-monovision versus multifocal intraocular lens implantation Journal of Cataract & Refractive Surgery, October 8, 2014    Clinical Article

10 Efficacy of selective laser trabeculoplasty in primary angle-closure glaucoma: a randomized clinical trial JAMA Ophthalmology, December 16, 2014    Evidence Based Medicine    Clinical Article

11 Prospective comparison of 3 dacryocystorhinostomy surgeries: external versus endoscopic versus transcanalicular multidiode laser Ophthalmic Plastic and Reconstructive Surgery, January 21, 2015    Clinical Article

12 Can eating blueberries really help you see better in the dark? American Chemical Society News, December 1, 2014

13 Implantation of a novel telemetric intraocular pressure sensor in patients with glaucoma (ARGOS Study): 1-year results Investigative Ophthalmology & Visual Science, January 26, 2015    Clinical Article

14 A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: The VOYAGER study British Journal of Ophthalmology, January 15, 2015    Clinical Article

15 Advances in cataract surgery: preserving the corneal endothelium Current Opinion in Ophthalmology, January 29, 2015    Review Article

16 Clinical impact of 8 prospective, randomized, multicenter glaucoma trials Journal of Glaucoma, January 12, 2015    Clinical Article

17 Femtosecond laser-assisted cataract surgery versus standard phacoemulsification cataract surgery: Outcomes and safety in more than 4000 cases at a single center Journal of Cataract & Refractive Surgery, November 17, 2014    Clinical Article

18 Long-term increase in subfoveal choroidal thickness after surgery for senile cataracts American Journal of Ophthalmology, January 8, 2015    Review Article    Clinical Article

19 Spectral-domain optical coherence tomography in hydroxychloroquine retinopathy Ophthalmology, January 2, 2015    Evidence Based Medicine    Review Article

20 Long-term results after primary intraocular lens implantation in children operated less than 2 years of age for congenital cataract Full Text Indian Journal of Ophthalmology, January 22, 2015    Free full text    Clinical Article

Indexed Journals in Ophthalmology: American Journal of Ophthalmology, Retina, Eye, Corneamore

Looking for a physician job? Let us help!

Register now for our free job placement service.
A career consultant will contact you soon.
Click Here for more information.

Get Started Now!

Free-of-charge, no obligation.

Terms and Conditions For M3 Career Consult

By registering with the M3 Career Consult service you authorize M3 USA Corporation to represent you in your job search. The following is a summary of the terms of our service and our mutual obligations to help you find a job:

  • You designate M3 to act as your agent and represent you in your job search;
  • You will not pay us for this service
  • You will advise us of any companies or positions to which you apply or have applied;
  • You will advise us if you believe you are not capable of performing a position for which we submit you, or for which you interview;
  • You will keep all information we provide you about companies or positions strictly confidential;
  • You will promptly provide us with information we request of you;
  • You will make yourself reasonably available for phone, video and in-person conversations and interviews;
  • You will be truthful in all of your communications with us; and
  • You will advise us if anything above changes.
 

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List